Adaptive Biotechnologies (ADPT) Competitor Comparison
We are evaluating the key criteria listed to compare Adaptive Biotechnologies (ADPT) against its competitors in the Biotechnology industry.
Market Capitalization
159 / 368Gross Profits
164 / 278Total Revenue
63 / 300EBITDA
266 / 337Free Cashflow
257 / 352Quick Ratio
200 / 357Earnings per Share
172 / 359Dividend yield
0 / 6Total Cash
82 / 358Performance 3 years
259 / 368Performance 5 years
234 / 368Performance 10 years
223 / 368Linearity 3 years
244 / 368Linearity 5 years
155 / 368Linearity 10 years
165 / 368Total Rank
32 / 368Dividend Rank
331 / 368Valuation Rank
29 / 368Piotroski Rank
55 / 368Muliplier Rank
109 / 368Market Capitalization - ADPT ranking 159 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.